HealthEquity (NASDAQ: HQY) reported Q4 EPS of $0.69, $0.03 worse than the analyst estimate of $0.72. Revenue for the quarter came in at $311.8 million versus the consensus estimate of $305.82 million.

GUIDANCE:

HealthEquity sees FY2026 EPS of $3.54-$3.74, versus the consensus of $3.76. HealthEquity sees FY2026 revenue of $1.28-1.305 billion, versus the consensus of $1.309 billion.

For earnings history and earnings-related data on HealthEquity (HQY) click here.